Explain regulatory steps of glycolysis with respect to name structure of intermediate enzyme and covector

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Loading Image
Here is a complete, structured explanation of the regulatory steps of glycolysis covering the intermediate/substrate, enzyme, and coenzyme (cofactor) at each regulated step.

Regulation of Glycolysis

Glycolysis is regulated at three physiologically irreversible (non-equilibrium) reactions. These are the major control points because a small change in their rate affects flux through the entire pathway.
Major sites of regulation in the glycolytic pathway

Step 1 - Glucose → Glucose 6-Phosphate

FeatureDetail
Intermediate (substrate)Glucose
ProductGlucose 6-phosphate (Glucose 6-P)
EnzymeHexokinase (all tissues) / Glucokinase (liver & pancreatic β-cells)
Coenzyme/CofactorATP → ADP (Mg²⁺ required)
Regulation typeAllosteric + product inhibition
Regulation details:
  • Hexokinase (isoenzymes I-III): has a high affinity for glucose (low Km ~0.1 mM), is inhibited by its own product - glucose 6-phosphate (product/feedback inhibition). It is saturated at normal blood glucose levels.
  • Glucokinase (hexokinase IV, liver): has a low affinity for glucose (high Km ~10 mM), is NOT inhibited by glucose 6-P, and is induced by insulin. It acts as a glucose sensor in the liver and pancreatic β-cells.
  • Both are irreversible under physiological conditions. Glucose 6-P is a metabolic branch point - it can enter glycolysis, the pentose phosphate pathway, or glycogen synthesis.

Step 2 - Fructose 6-Phosphate → Fructose 1,6-Bisphosphate

FeatureDetail
Intermediate (substrate)Fructose 6-phosphate (Fructose 6-P)
ProductFructose 1,6-bisphosphate (F-1,6-bisP)
EnzymePhosphofructokinase-1 (PFK-1) - the KEY rate-limiting enzyme
Coenzyme/CofactorATP → ADP (Mg²⁺ required)
Regulation typeAllosteric (most important regulatory site)
Regulation details:
PFK-1 is the committed, rate-limiting step of glycolysis - it is both inducible and subject to allosteric regulation.
RegulatorsEffectSignal meaning
AMPActivates (+)Low energy state - need more ATP
Fructose 2,6-bisphosphate (F-2,6-bisP)Activates (+)Fed state (insulin-driven)
ATP (high concentration)Inhibits (-)Energy is plentiful, slow down
CitrateInhibits (-)TCA cycle is running well, substrates not needed
H⁺ (low pH)Inhibits (-)Prevents lactic acidosis
Fructose 2,6-bisphosphate is a particularly powerful activator. It is synthesized by PFK-2 (a bifunctional enzyme). In the fed state, insulin-driven dephosphorylation of PFK-2 activates it, raising F-2,6-bisP levels and stimulating glycolysis in the liver. In the fasted state, glucagon activates PKA, phosphorylates PFK-2 (deactivating its kinase activity), and F-2,6-bisP falls, slowing glycolysis.
Key concept: AMP signals low energy because the adenylate kinase reaction (2 ADP → ATP + AMP) means AMP concentration rises manyfold even when ATP drops by only ~20%, making AMP a highly sensitive indicator of energy state.

Step 3 - Phosphoenolpyruvate (PEP) → Pyruvate

FeatureDetail
Intermediate (substrate)Phosphoenolpyruvate (PEP)
ProductPyruvate
EnzymePyruvate Kinase (PK)
Coenzyme/CofactorADP → ATP (Mg²⁺, K⁺ required); also generates ATP
Regulation typeAllosteric + covalent modification (liver isoenzyme only)
Regulation details:
RegulatorsEffectNotes
Fructose 1,6-bisphosphateActivates (+)Feed-forward activation - the product of PFK-1 activates PK
ATP (high)Inhibits (-)Energy is sufficient
AlanineInhibits (-)Signals sufficient amino acid pool
Glucagon (via cAMP/PKA)Inhibits (-)Liver L-isoenzyme only - phosphorylation inactivates it
  • In the liver, the L-isoenzyme of pyruvate kinase is subject to covalent regulation: glucagon → cAMP → PKA → phosphorylates PK → inhibits it (diverts PEP to gluconeogenesis).
  • In muscle, the M-isoenzyme is NOT regulated by phosphorylation.

The Non-Regulated But Coenzyme-Critical Step

Glyceraldehyde 3-Phosphate → 1,3-Bisphosphoglycerate

FeatureDetail
IntermediateGlyceraldehyde 3-phosphate (G3P)
EnzymeGlyceraldehyde 3-phosphate dehydrogenase (GAPDH)
CoenzymeNAD⁺ → NADH + H⁺ (the only redox step in glycolysis)
This is the only oxidation-reduction reaction in glycolysis. NAD⁺ is a mandatory coenzyme. If NAD⁺ is not regenerated (by lactate dehydrogenase in anaerobic conditions, or by the electron transport chain aerobically), GAPDH stops and glycolysis halts. This is why:
  • In anaerobic conditions: pyruvate + NADH → lactate + NAD⁺ (via LDH, which uses NADH as coenzyme)
  • Net per glucose: 2 ATP + 2 NADH + 2 pyruvate

Summary Table

StepSubstrate (Intermediate)EnzymeCoenzyme/CofactorKey Regulators
1GlucoseHexokinase / GlucokinaseATP (Mg²⁺)(-) Glucose 6-P (HK); not inhibited by G6P (GK)
2 (Rate-limiting)Fructose 6-PPFK-1ATP (Mg²⁺)(+) AMP, F-2,6-bisP; (-) ATP, citrate, H⁺
6 (Redox step)Glyceraldehyde 3-PGAPDHNAD⁺ (→ NADH)Availability of NAD⁺
10PhosphoenolpyruvatePyruvate KinaseADP (Mg²⁺, K⁺)(+) F-1,6-bisP; (-) ATP, alanine, glucagon (liver)

Coenzyme Summary

CoenzymeRole in Glycolysis
ATPPhosphate donor in steps 1 and 3 (investment phase); allosteric inhibitor of PFK-1 and PK
ADPPhosphate acceptor in steps 7 and 10 (ATP generation); AMP formed from 2 ADP activates PFK-1
NAD⁺Oxidizing agent in step 6 (GAPDH reaction); must be regenerated for glycolysis to continue
NADHProduced in step 6; inhibits pyruvate dehydrogenase; used by LDH anaerobically
Mg²⁺Cofactor for all kinase reactions (forms Mg-ATP complex)
Fructose 2,6-bisphosphateNot a coenzyme but the most potent allosteric activator of PFK-1

Sources: Basic Medical Biochemistry - A Clinical Approach, 6e, Chapter 22; Harper's Illustrated Biochemistry, 32nd Ed, Chapter 17
This is a shared conversation. Sign in to Orris to start your own chat.